Acadia Pharmaceuticals Inc (ACAD)

Acadia Pharmaceuticals Inc Aktie (ACAD) Neueste Nachrichten

ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 52-Week Low at $14.68 - MarketBeat

MarketBeat

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Business Wire

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by Victory Capital Management Inc. - Defense World

Defense World

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Up 7.8% in April - MarketBeat

MarketBeat

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Up 7.8% in April - MarketBeat

MarketBeat

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Purchased by Natixis Advisors L.P. - Defense World

Defense World

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by Swiss National Bank - Defense World

Defense World

Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Increases By 7.8% - Defense World

Defense World

M&G Investment Management Ltd. Acquires New Stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - MarketBeat

MarketBeat

NBIX: 3 Pharma Stocks to Buy for Potential Financial Fortunes - StockNews.com

StockNews.com

Acadia adds awareness-raising adventure series to site dedicated to documenting life with Rett syndrome - FiercePharma

FiercePharma

Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary ... - Yahoo Finance

Yahoo Finance

Investors five-year losses grow to 52% as the stock sheds US$212m this past week - Yahoo Movies UK

Yahoo Movies UK

When Can We Expect A Profit From ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? - Yahoo Movies UK

Yahoo Movies UK

Leerink Partnrs Weighs in on ACADIA Pharmaceuticals Inc.'s FY2026 Earnings (NASDAQ:ACAD) - MarketBeat

MarketBeat

Citigroup Lowers ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $30.00 - Defense World

Defense World

ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Cut to $27.00 - Defense World

Defense World

Jump Financial LLC Acquires 89,053 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - MarketBeat

MarketBeat

Bank of America Cuts ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $22.00 - Defense World

Defense World

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World

Defense World

ACADIA Pharmaceuticals (NASDAQ:ACAD) PT Lowered to $21.00 - Defense World

Defense World

Robert W. Baird Trims ACADIA Pharmaceuticals (NASDAQ:ACAD) Target Price to $28.00 - Defense World

Defense World

ACADIA Pharmaceuticals' (ACAD) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World

Defense World

ACADIA Pharmaceuticals Inc. Forecasted to Earn Q2 2024 Earnings of $0.09 Per Share (NASDAQ:ACAD) - Defense World

Defense World

ACADIA Pharmaceuticals (ACAD) Stock Forecast and Price Target 2024 - MarketBeat

MarketBeat

Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

Yahoo Finance

ACADIA Pharmaceuticals (NASDAQ:ACAD) PT Lowered to $22.00 - MarketBeat

MarketBeat

Truist Financial Corp Sells 32824 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - Defense World

Defense World

ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Yahoo Finance

ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 1-Year Low Following Analyst Downgrade - Defense World

Defense World

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Business Wire

Business Wire

Oversold Conditions For Acadia Pharmaceuticals (ACAD) - Nasdaq

Nasdaq

Earnings call: ACADIA Pharmaceuticals posts robust Q1 2024 results - Investing.com

Investing.com

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Why Is Acadia (ACAD) Up 1% Since Last Earnings Report? - Yahoo Movies UK

Yahoo Movies UK

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss - Zacks Investment Research

Zacks Investment Research

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss - Yahoo Finance

Yahoo Finance

Oversold Conditions For Acadia Pharmaceuticals (ACAD) - Nasdaq

Nasdaq

Acadia: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates - Yahoo Finance UK

Yahoo Finance UK

Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates - Zacks Investment Research

Zacks Investment Research

Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview - Business Wire

Business Wire

Is ACADIA Pharmaceuticals (ACAD) Stock Outpacing Its Medical Peers This Year? - Yahoo Movies Canada

Yahoo Movies Canada

Is ACADIA Pharmaceuticals (ACAD) Stock Outpacing Its Medical Peers This Year? - Yahoo Movies Canada

Yahoo Movies Canada

ACADIA Pharmaceuticals' (ACAD) Market Perform Rating Reaffirmed at Oppenheimer - Defense World

Defense World

Ligand Pharmaceuticals (LGND) Tops Q1 Earnings Estimates

Zacks Investment Research

Acadia (ACAD) Up 12% Since Last Earnings Report: Can It Continue? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Zacks Investment Research

Insider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CFO Sells 3503 Shares of Stock - Defense World

Defense World

Insider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Insider Sells 1326 Shares of Stock - Defense World

Defense World